Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fermentek
Jerusalem, Jerusalem District, Israel
- Ownership
- Private
- Development stage
- Other
01
Overview
Fermentek manufactures pure mycotoxins and rare antibiotics primarily used as standards for food analysis and biomedical research. Products are intended for preclinical, reference, and analytical laboratory use. The company supplies the entire global demand for certain standards, e.g., Aflatoxin M2, and offers highly standardized calibrant solutions (FermaSol family).
- Therapeutic areas
- Other
- Modalities
- Small moleculeBiologicProtein
- Industry
- Chemicals & Materials
02
Partnerships
Major international distributors of chemical standards in research markets; specific distributors not disclosed
Beyond the preview
Go deeper on Fermentek.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fermentek.